Atlas Trials

Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT00051025 · COMPLETED

Trial details

NCT number
NCT00051025
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's LymphomaLymphoma, B-cellLymphoma, Low-grade
Start date
2000-05-01
Primary completion
2001-01-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.